Kitching AR, Anders H-J, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71. https://doi.org/10.1038/s41572-020-0204-y. (PubMed PMID: 32855422).

Article  PubMed  Google Scholar 

Jennette J, Falk R, Bacon P, Basu N, Cid M, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. https://doi.org/10.1002/art.37715. (PubMed PMID: 23045170).

Article  CAS  PubMed  Google Scholar 

Cohen Tervaert JW, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Clin Rev Allergy Immunol. 2012;43(3):211–9. https://doi.org/10.1007/s12016-012-8320-4. (PubMed PMID: 22669754).

Article  CAS  PubMed  Google Scholar 

Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23. https://doi.org/10.1056/NEJMoa1108735. (PubMed PMID: 22808956).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U. ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570–9. https://doi.org/10.1038/nrrheum.2016.123. (PubMed PMID: 27464484).

Article  CAS  PubMed  Google Scholar 

Berglin E, Mohammad AJ, Dahlqvist J, Johansson L, Eriksson C, Sjöwall J, et al. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study J Autoimmun. 2021;117: 102579. https://doi.org/10.1016/j.jaut.2020.102579. (PubMed PMID: 33340843).

Article  CAS  PubMed  Google Scholar 

Unizony S, Villarreal M, Miloslavsky E, Lu N, Merkel P, Spiera R, et al. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. 2016;75(6):1166–9. https://doi.org/10.1136/annrheumdis-2015-208073. (PubMed PMID: 26621483).

Article  CAS  PubMed  Google Scholar 

Windpessl M, Bettac EL, Gauckler P, Shin JI, Geetha D, Kronbichler A. ANCA status or clinical phenotype—what counts more? Curr Rheumatol Rep. 2021;23(6):37. https://doi.org/10.1007/s11926-021-01002-0. (PubMed PMID: 33909191).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grayson P, Ponte C, Suppiah R, Robson J, Craven A, Judge A, et al. 2022 American college of rheumatology/European alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):309–14. https://doi.org/10.1136/annrheumdis-2021-221794. (PubMed PMID: 35110334).

Article  PubMed  Google Scholar 

Robson J, Grayson P, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American college of rheumatology/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):315–20. https://doi.org/10.1136/annrheumdis-2021-221795. (PubMed PMID: 35110333).

Article  PubMed  Google Scholar 

Suppiah R, Robson J, Grayson P, Ponte C, Craven A, Khalid S, et al. 2022 American college of rheumatology/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81(3):321–6 (PubMed PMID: 35110332).

Article  PubMed  Google Scholar 

Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7 (PubMed PMID: 16901958).

Article  PubMed  Google Scholar 

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–32. https://doi.org/10.1136/ard.2008.101279. (PubMed PMID: 19054820).

Article  CAS  PubMed  Google Scholar 

Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):33–9 (PubMed PMID: 8808107).

Article  CAS  PubMed  Google Scholar 

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):23–32 (PubMed PMID: 8808106).

Article  CAS  PubMed  Google Scholar 

Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628–36. https://doi.org/10.1681/ASN.2010050477. (PubMed PMID: 20616173).

Article  PubMed  Google Scholar 

Chen Y, Bao H, Liu Z, Liu X, Gao E, Zeng C, et al. Risk factors for renal survival in Chinese patients with myeloperoxidase-ANCA-associated GN. Clin J Am Soc Nephrol. 2017;12(3):417–25. https://doi.org/10.2215/CJN.06200616. (PubMed PMID: 28148558).

Article  PubMed  PubMed Central  Google Scholar 

Lin W, Shen C, Zhong Y, Ooi JD, Eggenhuizen P, Zhou Y-O, et al. Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival. Front Immunol. 2021;12: 625672. https://doi.org/10.3389/fimmu.2021.625672. (PubMed PMID: 33841408).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 2018;94(6):1177–88. https://doi.org/10.1016/j.kint.2018.07.020. (PubMed PMID: 30385041).

Article  CAS  PubMed  Google Scholar 

KDIGO. Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021. https://doi.org/10.1016/j.kint.2021.05.021. (PubMed PMID: 34556256).

Article  Google Scholar 

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–94. https://doi.org/10.1136/annrheumdis-2016-209133. (PubMed PMID: 27338776).

Article  CAS  PubMed  Google Scholar 

Huang L, Shen C, Zhong Y, Ooi JD, Zhou Y-O, Chen J-B, et al. The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis. Clin Exp Med. 2020;20(3):401–8. https://doi.org/10.1007/s10238-020-00629-0. (PubMed PMID: 32318926).

Article  CAS  PubMed  Google Scholar 

Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023. https://doi.org/10.1136/ard-2022-223764. (PubMed PMID: 36927642).

Article  Google Scholar 

Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66(5):605–17 (PubMed PMID: 17170053).

Article  CAS  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12 (PubMed PMID: 19414839).

Article  PubMed  PubMed Central  Google Scholar 

Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA. Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford). 2017;56(11):1962–9. https://doi.org/10.1093/rheumatology/kex293. (PubMed PMID: 28968886).

Article  CAS  PubMed  Google Scholar 

Kim SM, Choi S-Y, Kim SY, Kim J. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Rheumatol Int. 2019;39(11):1919–26. https://doi.org/10.1007/s00296-019-04447-w. (PubMed PMID: 31552433).

Article  CAS  PubMed  Google Scholar 

Chou J, Randall K, Gatenby P. Clinical outcomes of patients with dual positivity for proteinase 3 and myeloperoxidase specific antineutrophil cytoplasmic antibodies. Int Med J. 2014;44:7 (PubMed PMID: WOS:000342722800020).

Google Scholar 

Elias John E, Roy S, Sundar Raj Mani S, Joseph Eapen J, Mishra U, Varughese S. Rare case of renal limited dual anti-neutrophil cytoplasmic antibody-associated vasculitis: double trouble! Eur J Case Rep Intern Med. 2022;9(5):003365. https://doi.org/10.1290/2022_003365. (PubMed PMID: 35774735).

Article  PubMed  PubMed Central  Google Scholar 

Huang L, Shen C, Zhong Y, Ooi JD, Zhou Y-O, Chen J-B, et al. Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis. Clin Exp Med. 2020;20(2):199–206. https://doi.org/10.1007/s10238-020-00614-7. (PubMed PMID: 32078076).

Article  CAS  PubMed  Google Scholar 

de Joode AAE, Sanders JSF, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8(10):1709–17. https://doi.org/10.2215/CJN.01020113. (PubMed PMID: 23846462).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bantis K, Stangou MJ, Kalpakidis S, Nikolaidou C, Lioulios G, Mitsoglou Z, et al. Different types of ANCA determine different clinical phenotypes and outcome in ANCA-associated vasculitis (AAV). Front Med (Lausanne). 2021;8: 783757. https://doi.org/10.3389/fmed.2021.783757. (PubMed PMID: 35127750).

Article  PubMed  Google Scholar 

Murosaki T, Sato T, Akiyama Y, Nagatani K, Minota S. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Mod Rheumatol. 2017. https://doi.org/10.1080/14397595.2016.1192760. (PubMed PMID: 27320904).

Article  PubMed